A new UK Biobank analysis identified a plasma-protein signature that can predict rheumatoid arthritis onset years before diagnosis. Researchers linked 213 proteins to future disease development and trained a model that achieved an AUC of 0.915, forecasting RA up to three years prior to clinical diagnosis. The study adds to the growing push for pre-symptomatic risk stratification using proteomics paired with machine learning. It also suggests a route to earlier monitoring and potential intervention studies. For biotech platforms focused on early detection, the work reinforces protein-level predictors as actionable biomarkers where genetic signals alone may be insufficient.